|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 409.85 INR | -1.07% |
|
-0.76% | -0.49% |
| 08-03 | Aarti Drugs Limited, Q1 2027 Earnings Call, Aug 03, 2026 | |
| 07-31 | Aarti Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 37.81B 398M 345M 322M 296M 559M 565M 3.79B 1.48B 18.9B 1.49B 1.46B 62.63B | P/E 2026 |
15x | P/E 2027 * | 18.5x |
|---|---|---|---|---|---|
| Enterprise Value | 37.81B 398M 345M 322M 296M 559M 565M 3.79B 1.48B 18.9B 1.49B 1.46B 62.63B | EV / Sales 2026 |
1.14x | EV / Sales 2027 * | 1.28x |
| Free-Float |
39.83% | Yield 2026 * |
0.97% | Yield 2027 * | 1.42% |
Last Transcript: Aarti Drugs Limited
| 22-12-28 | Aarti Drugs : Loss of Share Certificates | PU |
| 22-07-10 | Aarti Drugs : Newspaper Advertisements | PU |
| 1 day | -1.07% | ||
| 1 week | -0.76% | ||
| Current month | -3.22% | ||
| 1 month | +7.98% | ||
| 3 months | +4.83% | ||
| 6 months | +9.53% | ||
| Current year | -0.49% |
| 1 week | 404.65 |  | 449 |
| 1 month | 377.85 | | 449 |
| Current year | 318.6 | | 449 |
| 1 year | 318.6 | | 534.15 |
| 3 years | 312.5 | | 634.9 |
| 5 years | 310.8 | | 669.4 |
| 10 years | 104.82 | | 1,025 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 80 | - | |
| Chief Executive Officer | 79 | 2007-05-31 | |
Adhish P. Patil
DFI | Director of Finance/CFO | 43 | 2012-07-05 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 79 | 2014-03-31 | |
| Director/Board Member | 62 | 2007-05-31 | |
| Chairman | 80 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.07% | -0.76% | -14.85% | -26.82% | 398M | |
| -0.51% | -8.60% | +45.08% | +148.21% | 995B | |
| +0.20% | -4.42% | +49.05% | +50.81% | 614B | |
| -0.53% | -7.37% | +23.64% | +65.03% | 431B | |
| +0.99% | -0.11% | +41.46% | +36.42% | 353B | |
| +0.08% | -3.95% | +30.53% | +38.70% | 293B | |
| -1.00% | -11.45% | +3.65% | +6.83% | 245B | |
| -3.67% | -12.72% | -3.55% | -45.93% | 210B | |
| +2.94% | -0.78% | +29.17% | +60.32% | 210B | |
| +3.13% | +0.69% | +18.11% | +71.90% | 168B | |
| Average | +0.15% | -4.44% | +22.23% | +40.55% | 351.86B | |
| Weighted average by Cap. | +0.24% | -5.89% | +33.55% | +70.38% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 26.07B 274M 238M 222M 204M 385M 390M 2.62B 1.02B 13.03B 1.03B 1.01B 43.17B | 29.45B 310M 269M 251M 230M 436M 440M 2.96B 1.16B 14.72B 1.16B 1.14B 48.78B |
| Net income | 1.82B 19.15M 16.63M 15.51M 14.25M 26.94M 27.24M 183M 71.47M 911M 71.93M 70.35M 3.02B | 2.15B 22.62M 19.64M 18.32M 16.83M 31.82M 32.17M 216M 84.41M 1.08B 84.96M 83.1M 3.56B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-05 | ₹409.85 | -1.07% | 7,067 |
| 26-08-04 | ₹414.30 | +1.77% | 5,284 |
| 26-08-03 | ₹407.10 | -3.87% | 52,666 |
| 26-07-31 | ₹423.50 | +2.64% | 9,820 |
| 26-07-30 | ₹412.60 | -0.10% | 8,863 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- AARTIDRUGS Stock
Select your edition
All financial news and data tailored to specific country editions
